FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041031356> ?p ?o ?g. }

• W2041031356 endingPage "1285" @default.
• W2041031356 startingPage "1277" @default.
• W2041031356 abstract "Background: Preliminary evidence suggests that clozapine relieves the craving for psychoactive substances in schizophrenia patients. Quetiapine shares crucial pharmacological properties with clozapine. Promising results have been described with quetiapine therapy in patients with psychosis and substance use disorder.Methods: Based on Diagnostic and Statistical Manual of Mental Disorders – fourth edition (DSM‐IV) criteria, patients were diagnosed with comorbid schizophrenia-spectrum and substance use disorders. Patients were switched to quetiapine for a 12‐week open-label trial. Craving, quantities used, days of consumption, and severity of substance abuse were assessed every 3 weeks. Alcohol and Drug Use Scales were administered on baseline and end-point. Psychiatric symptoms, depressive symptoms, extrapyramidal symptoms, and cognition were also assessed at baseline, week 6 and week 12.Results: Twenty-four schizophrenia-spectrum patients were included in the last observation carried forward (LOCF) analyses, responding to one or more of the following substance use disorders: cannabis (15 patients), alcohol (10 patients), and other psychoactive substances (nine patients). Overall, severity of substance abuse improved during the study. Less weekly days were spent on drugs of abuse. A decrease in the weekly Canadian dollars spent on psychoactive substances was also observed. Cognition, psychiatric, depressive, and extrapyramidal symptoms also significantly improved ( p < 0.05).Conclusions: In this open-label, uncontrolled trial, significant improvements were noted in substance abuse, psychiatric symptoms, extrapyramidal symptoms, and cognition during quetiapine therapy. The study suffered from three main limitations: (1) the open-label design of the study; (2) the patients’ poor compliance; and (3) the small sample size involved. Controlled studies on the use of quetiapine in dual diagnosis schizophrenia are warranted to confirm that the effects are drug-related." @default.
• W2041031356 created "2016-06-24" @default.
• W2041031356 creator A5009174972 @default.
• W2041031356 creator A5022301411 @default.
• W2041031356 creator A5025732576 @default.
• W2041031356 creator A5032024974 @default.
• W2041031356 creator A5043353145 @default.
• W2041031356 creator A5044782433 @default.
• W2041031356 creator A5074210849 @default.
• W2041031356 creator A5088532478 @default.
• W2041031356 creator A5090820982 @default.
• W2041031356 date "2006-05-31" @default.
• W2041031356 modified "2023-10-16" @default.
• W2041031356 title "Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial" @default.
• W2041031356 cites W165714740 @default.
• W2041031356 cites W1809232082 @default.
• W2041031356 cites W1978713867 @default.
• W2041031356 cites W1994428974 @default.
• W2041031356 cites W1995760805 @default.
• W2041031356 cites W1999689270 @default.
• W2041031356 cites W2009052798 @default.
• W2041031356 cites W2023504580 @default.
• W2041031356 cites W2026188485 @default.
• W2041031356 cites W2031192891 @default.
• W2041031356 cites W2035049841 @default.
• W2041031356 cites W2043923015 @default.
• W2041031356 cites W2073023197 @default.
• W2041031356 cites W2076371841 @default.
• W2041031356 cites W2076704115 @default.
• W2041031356 cites W2081420935 @default.
• W2041031356 cites W2095213614 @default.
• W2041031356 cites W2100233372 @default.
• W2041031356 cites W2109481947 @default.
• W2041031356 cites W2115115146 @default.
• W2041031356 cites W2119369900 @default.
• W2041031356 cites W2122592499 @default.
• W2041031356 cites W2136550122 @default.
• W2041031356 cites W2138120070 @default.
• W2041031356 cites W2158773829 @default.
• W2041031356 cites W2168638282 @default.
• W2041031356 cites W2169269570 @default.
• W2041031356 cites W2329510271 @default.
• W2041031356 doi "https://doi.org/10.1185/030079906x112561" @default.
• W2041031356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16834826" @default.
• W2041031356 hasPublicationYear "2006" @default.
• W2041031356 type Work @default.
• W2041031356 sameAs 2041031356 @default.
• W2041031356 citedByCount "65" @default.
• W2041031356 countsByYear W20410313562012 @default.
• W2041031356 countsByYear W20410313562014 @default.
• W2041031356 countsByYear W20410313562015 @default.
• W2041031356 countsByYear W20410313562016 @default.
• W2041031356 countsByYear W20410313562018 @default.
• W2041031356 countsByYear W20410313562019 @default.
• W2041031356 countsByYear W20410313562020 @default.
• W2041031356 countsByYear W20410313562021 @default.
• W2041031356 countsByYear W20410313562022 @default.
• W2041031356 countsByYear W20410313562023 @default.
• W2041031356 crossrefType "journal-article" @default.
• W2041031356 hasAuthorship W2041031356A5009174972 @default.
• W2041031356 hasAuthorship W2041031356A5022301411 @default.
• W2041031356 hasAuthorship W2041031356A5025732576 @default.
• W2041031356 hasAuthorship W2041031356A5032024974 @default.
• W2041031356 hasAuthorship W2041031356A5043353145 @default.
• W2041031356 hasAuthorship W2041031356A5044782433 @default.
• W2041031356 hasAuthorship W2041031356A5074210849 @default.
• W2041031356 hasAuthorship W2041031356A5088532478 @default.
• W2041031356 hasAuthorship W2041031356A5090820982 @default.
• W2041031356 hasConcept C118552586 @default.
• W2041031356 hasConcept C2776412080 @default.
• W2041031356 hasConcept C2777056318 @default.
• W2041031356 hasConcept C2779541405 @default.
• W2041031356 hasConcept C2779727114 @default.
• W2041031356 hasConcept C2780494398 @default.
• W2041031356 hasConcept C2780616385 @default.
• W2041031356 hasConcept C2780634440 @default.
• W2041031356 hasConcept C2780864610 @default.
• W2041031356 hasConcept C40010229 @default.
• W2041031356 hasConcept C48856860 @default.
• W2041031356 hasConcept C71924100 @default.
• W2041031356 hasConceptScore W2041031356C118552586 @default.
• W2041031356 hasConceptScore W2041031356C2776412080 @default.
• W2041031356 hasConceptScore W2041031356C2777056318 @default.
• W2041031356 hasConceptScore W2041031356C2779541405 @default.
• W2041031356 hasConceptScore W2041031356C2779727114 @default.
• W2041031356 hasConceptScore W2041031356C2780494398 @default.
• W2041031356 hasConceptScore W2041031356C2780616385 @default.
• W2041031356 hasConceptScore W2041031356C2780634440 @default.
• W2041031356 hasConceptScore W2041031356C2780864610 @default.
• W2041031356 hasConceptScore W2041031356C40010229 @default.
• W2041031356 hasConceptScore W2041031356C48856860 @default.
• W2041031356 hasConceptScore W2041031356C71924100 @default.
• W2041031356 hasIssue "7" @default.
• W2041031356 hasLocation W20410313561 @default.
• W2041031356 hasLocation W20410313562 @default.
• W2041031356 hasOpenAccess W2041031356 @default.
• W2041031356 hasPrimaryLocation W20410313561 @default.
• W2041031356 hasRelatedWork W1970998752 @default.

• next